Honest Company, Inc. HNST
Institutional shares held
69.5 Million
119K
calls
242K
puts
Total value of holdings
$479M
$820K
calls
$1.67M
puts
Market Cap
$637M
92,416,400
Shares Out.
Institutional ownership
75.21%
# of Institutions
153
We take great care to ensure that the data presented and summarized in this overview for Honest Company, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding HNST
View all-
Institutional Venture Management Xiii, LLC Menlo Park, CA10.5MShares$72.2 Million24.36% of portfolio
-
Catterton Management Company, L.L.C. Greenwich, CT9.35MShares$64.4 Million25.14% of portfolio
-
Portolan Capital Management, LLC Boston, MA7.67MShares$52.8 Million2.17% of portfolio
-
Black Rock Inc. New York, NY4.98MShares$34.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.1MShares$28.2 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.16MShares$21.8 Million0.16% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2.01MShares$13.9 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.97MShares$13.6 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.81MShares$12.5 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.52MShares$10.4 Million0.0% of portfolio
Latest Institutional Activity in HNST
Top Purchases
Top Sells
About HNST
The Honest Company, Inc. manufactures and sells diapers and wipes, skin and personal care, and household and wellness products. The company also offers baby clothing and nursery bedding products. It sells its products through digital and retail sales channels, such as its website and third-party ecommerce sites, as well as brick and mortar retailers. The company was incorporated in 2012 and is headquartered in Los Angeles, California.
Insider Transactions at HNST
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2024
|
Jessica Warren Director |
SELL
Open market or private sale
|
Direct |
465,000
-28.44%
|
$3,255,000
$7.55 P/Share
|
|
Dec 10
2024
|
Jessica Warren Director |
BUY
Exercise of conversion of derivative security
|
Direct |
465,000
+22.14%
|
$2,325,000
$5.12 P/Share
|
|
Nov 27
2024
|
Brendan Sheehey General Counsel |
SELL
Open market or private sale
|
Direct |
92,138
-8.13%
|
$737,104
$8.13 P/Share
|
|
Nov 27
2024
|
Brendan Sheehey General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+8.11%
|
$500,000
$5.66 P/Share
|
|
Nov 25
2024
|
Andrea Turner Director |
SELL
Open market or private sale
|
Direct |
25,000
-11.1%
|
$200,000
$8.49 P/Share
|
|
Nov 20
2024
|
James D White Director |
SELL
Open market or private sale
|
Direct |
25,000
-8.08%
|
$175,000
$7.19 P/Share
|
|
Nov 20
2024
|
Carla Vernon Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
65,176
-2.3%
|
$456,232
$7.1 P/Share
|
|
Nov 20
2024
|
Katherine Barton Chief Growth Officer |
SELL
Open market or private sale
|
Direct |
23,884
-2.61%
|
$167,188
$7.1 P/Share
|
|
Nov 20
2024
|
Brendan Sheehey General Counsel |
SELL
Open market or private sale
|
Direct |
8,392
-1.6%
|
$58,744
$7.1 P/Share
|
|
Nov 20
2024
|
David Loretta Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
27,004
-2.73%
|
$189,028
$7.1 P/Share
|
|
Nov 20
2024
|
Thomas Sternweis SVP, Enterprise Dev. & Strat. |
SELL
Open market or private sale
|
Direct |
1,515
-0.64%
|
$10,605
$7.1 P/Share
|
|
Nov 20
2024
|
Stephen Winchell EVP, Operations and R&D |
SELL
Open market or private sale
|
Direct |
7,123
-1.83%
|
$49,861
$7.1 P/Share
|
|
Nov 20
2024
|
Jonathan Mayle SVP, Customer Sales |
SELL
Open market or private sale
|
Direct |
2,332
-0.84%
|
$16,324
$7.1 P/Share
|
|
Nov 18
2024
|
Brendan Sheehey General Counsel |
SELL
Open market or private sale
|
Direct |
107,653
-9.36%
|
$753,571
$7.01 P/Share
|
|
Nov 18
2024
|
Brendan Sheehey General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
115,000
+9.08%
|
$575,000
$5.66 P/Share
|
|
Nov 18
2024
|
Stephen Winchell EVP, Operations and R&D |
SELL
Open market or private sale
|
Direct |
25,000
-6.03%
|
$175,000
$7.08 P/Share
|
|
Nov 15
2024
|
Jonathan Mayle SVP, Customer Sales |
SELL
Open market or private sale
|
Direct |
21,000
-7.04%
|
$126,000
$6.5 P/Share
|
|
Sep 18
2024
|
Thc Shared Abacus, LP |
SELL
Open market or private sale
|
Direct |
2,300,000
-18.9%
|
$6,900,000
$3.5 P/Share
|
|
Aug 21
2024
|
David Loretta Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
75,656
-7.11%
|
$302,624
$4.28 P/Share
|
|
Aug 21
2024
|
Stephen Winchell EVP, Operations and R&D |
SELL
Open market or private sale
|
Direct |
6,938
-1.65%
|
$27,752
$4.28 P/Share
|
Last 12 Months Summary
Buy / Acquisition
4.29M
Shares
From
16
Insiders
| Grant, award, or other acquisition | 3.61M shares |
|---|---|
| Exercise of conversion of derivative security | 680K shares |
Sell / Disposition
4.7M
Shares
From
11
Insiders
| Open market or private sale | 4.7M shares |
|---|